Drug or pharmaceutical formulation development involves combining the drug’s active pharmaceutical ingredient (API) with other inactive components (excipients) to generate a final drug product. Formulation development and subsequent analytical testing are among the most critical aspects of a drug’s clinical development pipeline.
A well-developed formulation ensures the stability of the API, ascertains the route and ease of administration of the drug, affects solubility and influences the drug’s bioavailability and toxicity profiles. On the other hand, deficiencies in a formulation can lead to significant delays and can have negative implications late in the drug’s development process.
At Emery Pharma, we have significant experience with all aspects of formulation development: pre-formulation studies, formulation trials, functional assays, stability assessments, analytical testing, and bioavailability and ADME studies. We are happy to be the partnering lab for Clients considering formulation development.